H&T Presspart sell "eMDI Connected Metered-Dose Inhaler"

H&T Presspart has developed the first market-ready, fully embedded, connected metered-dose inhaler (eMDI). By tracking and recording medication-use data and sharing it with patients and physicians through a mobile or web app, it helps pharmaceutical manufacturers deliver better care to people with asthma and COPD. The eMDI supports medication adherence, encourages self-care, and lets health professionals monitor patients in real time. It can integrate with a mobile health app that tracks both controller and rescue medications, transferring data wirelessly to a smartphone app or directly into a patient's medical record.